Hemophilia A: all 885 studies
Page 4 of 9. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.
- Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B PatientsCompletedNCT01174446Phase 3Results posted
- Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia ACompletedNCT01138501Phase 3Results posted
- Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia ACompletedNCT01125813Phase 3Results posted
- Canadian Hemophilia Prophylaxis StudyCompletedNCT01085344Phase 4Results posted
- Survey of Inhibitors in Plasma-Product Exposed ToddlersCompletedNCT01064284Phase 4Results posted
- Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia ACompletedNCT01029340Phase 3Results posted
- Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia BCompletedNCT01027364Phase 3Results posted
- Efficacy and Safety of IL-11 in DDAVP UnresponsiveCompletedNCT00994929Phase 2Results posted
- Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia ACompletedNCT00989196Phase 2Results posted
- Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015CompletedNCT00984126Phase 3Results posted
- Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for InjectionCompletedNCT00952822Phase 1Results posted
- Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care SettingCompletedNCT00950170Phase 4Results posted
- Study of Ataluren (PTC124) in Hemophilia A and BTerminatedNCT00947193Phase 2Results posted
- Study Evaluating Liver Transplantation in Haemophilia Patients in SpainCompletedNCT00927992Results posted
- Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia ACompletedNCT00916032Phase 4Results posted
- Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A PatientsCompletedNCT00914459Phase 4Results posted
- Study Evaluating Pharmacovigilance Of Refacto AFCompletedNCT00895037Results posted
- Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care SettingsTerminatedNCT00884390Phase 4Results posted
- PROPACT: Retrospective Prophylaxis Patient Case CollectionCompletedNCT00882778Results posted
- Study Evaluating On-Demand Treatment Of Xyntha In Chinese SubjectsCompletedNCT00868530Phase 3Results posted
- Study Evaluating On-Demand Treatment With BeneFIX In Chinese SubjectsCompletedNCT00866606Phase 3Results posted
- Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer InhibitorCompletedNCT00851721Phase 3Results posted
- Safety and Efficacy of Turoctocog Alfa in Haemophilia A SubjectsCompletedNCT00840086Phase 3Results posted
- Post Marketing Observational Study of Reformulated BeneFIXCompletedNCT00835068Results posted
- Study of Recombinant Factor IX Product, IB1001, in Subjects With Hemophilia BCompletedNCT00768287Phase 2/3Results posted
- Study Evaluating The Safety Of Xyntha In Usual Care SettingsTerminatedNCT00765726Phase 4Results posted
- Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of AgeTerminatedNCT00759655Phase 3Results posted
- Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IXCompletedNCT00749476Phase 4Results posted
- Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia ACompletedNCT00717626Phase 2Results posted
- Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsCompletedNCT00703911Results posted
- Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia ACompletedNCT00666406Phase 4Results posted
- Clinical Trial of Factor XIII (FXIII) ConcentrateCompletedNCT00640289Not applicableResults posted
- Russian Kogenate Pediatric StudyCompletedNCT00632814Phase 4Results posted
- BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia ATerminatedNCT00623727Phase 2Results posted
- Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic TreatmentCompletedNCT00623480Phase 3Results posted
- BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)CompletedNCT00586521Phase 4Results posted
- Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand PatientsTerminatedNCT00555555Phase 4Results posted
- Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIIICompletedNCT00543439Phase 3Results posted
- Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedNCT00486278Phase 2Results posted
- Post Marketing Surveillance To Observe Safety and Efficacy Of BeneFIX In Patients With Hemophilia BCompletedNCT00484185Results posted
- Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia BCompletedNCT00364182Phase 3Results posted
- Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic SurgeryCompletedNCT00357656Phase 4Results posted
- Rituximab to Treat Severe Hemophilia ACompletedNCT00331006Phase 2Results posted
- Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia ACompletedNCT00323856Phase 4Results posted
- Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia ATerminatedNCT00306670Phase 2/3Results posted
- Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia ACompletedNCT00289536Phase 4Results posted
- Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major SurgeryCompletedNCT00243659Phase 3Results posted
- Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia ACompletedNCT00243386Phase 4Results posted
- Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With InhibitorsCompletedNCT00221195Phase 2/3Results posted
- Study Evaluating Refacto For PharmacovigilanceCompletedNCT00195442Results posted
- Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A PatientsCompletedNCT00157157Phase 3Results posted
- Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia PatientsCompletedNCT07691437Not applicable
- Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.Active, not recruitingNCT07684898Phase 3
- Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand TreatmentActive, not recruitingNCT07663903Phase 3
- Effects of Photobiomodulation in Hemophilia Patients.CompletedNCT07579585Not applicable
- To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia AActive, not recruitingNCT07548411Phase 1/2
- Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults With Hemophilia and Hemophilic ArthropathyCompletedNCT07516730
- EPOCH-Economics and Patient Outcomes in China in HaemophiliaActive, not recruitingNCT07454239
- Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia AActive, not recruitingNCT07439055Phase 2/3
- Validity and Reliability of the Two-minute Step Test in HemophiliaCompletedNCT07425327
- Physiotherapy to Improve Balance and Walking Capacity in HemophiliaCompletedNCT07339410Not applicable
- Balance Evaluation in Adult HemophiliaCompletedNCT07243912
- A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy PeopleCompletedNCT07238816Phase 1
- Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic SynovitisCompletedNCT07187661Not applicable
- A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.Active, not recruitingNCT07161687
- Effects of Ultrasound and Infrared on Joint Pain and Movement in Hemophilia A Patients.CompletedNCT07116993Not applicable
- Central Sensitisation in Patients With Haemophilia and Degenerative ArthropathyCompletedNCT07110675
- Data Registry in Chinese Hemophilia A and B PatientsCompletedNCT07101224
- Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog AlfaActive, not recruitingNCT06940830Phase 4
- Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia PatientsActive, not recruitingNCT06922045Phase 3
- Examination of Physiotherapists' Knowledge, Awareness and Competence on Physical Activity and Exercise in Hemophilia PatientsCompletedNCT06879392
- A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa ProphylaxisActive, not recruitingNCT06752850Phase 4
- Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII ProductsCompletedNCT06738485Phase 3
- Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog AlfaActive, not recruitingNCT06716814Phase 3
- Home Monitoring in Hemophilia ATerminatedNCT06702579
- A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in TaiwanActive, not recruitingNCT06684314
- A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy MenCompletedNCT06649630Phase 1
- Comparison of Pulmonary Function, Exercise Capacity, and Physical Activity Level Between Children With Hemophilia and Healthy ControlsCompletedNCT06636565
- Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & BWithdrawnNCT06634836
- Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From HaemophiliaCompletedNCT06580340Not applicable
- Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia ACompletedNCT06579144Phase 1
- Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A PatientsCompletedNCT06574984
- The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical TrialTerminatedNCT06568302Phase 3
- Individualized Exercise Combined With Manual Therapy in Severe Hemophilia Patients With PolyarthropathyCompletedNCT06535971Not applicable
- Goal Attainment and Physical Activity in People With Hemophilia ATerminatedNCT06530030
- Case and Use Scenario Study to Gain Knowledge on the User Needs for a Medical Device for Hemophilia a MonitoringCompletedNCT06369740
- Real-life Clinical FEIBA Samples Measured Using the Version A of the HemA EnzySystemCompletedNCT06357572
- Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded StudyWithdrawnNCT06345833Early Phase 1
- Physiotherapy and Reaction Time in HemophiliaCompletedNCT06331091Not applicable
- A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia AActive, not recruitingNCT06297655Phase 3
- Study of a Gene Therapy Treatment for Hemophilia AWithdrawnNCT06297486Phase 3
- Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with InhibitorCompletedNCT06289166Phase 2
- Changes in Intra-articular Parameters by Doppler Ultrasound in Patients With Hemophilic Ankle ArthropathyCompletedNCT06281340Not applicable
- Version Testing of EnzySystem Version A for Hemophilia ASuspendedNCT06273865
- Conditioned Pain Modulation in Patients With HemophiliaStatus unknownNCT06267209
- Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Ankle ArthropathyCompletedNCT06261593Not applicable
- Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia AActive, not recruitingNCT06224907Phase 3
- EVALUATION of the OVERALL HAEMOSTATIC CAPACITY of MIM8 with GLOBAL HAEMOSTASIS ASSAYS and FIBRIN CLOT ULTRASTRUCTURECompletedNCT06212505
- Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With HemophiliaCompletedNCT06191068
- A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia AActive, not recruitingNCT06185335Phase 1/2